Since Septerna’s inception in 2019, the company had raised $224.2 million prior to the IPO, most recently a $150 million Series B round last year led by RA Capital Management.That firm holds a 7 ...

Septerna, Inc. is a clinical-stage biotechnology company pioneering a new era of GPCR oral small molecule drug discovery powered by its proprietary Native Complex Platform™.

Septerna’s approach goes beyond finding new binding locations for small molecules. The conventional thinking about GPCRs is that these receptors are like on/off switches—drugs that bind to ...

Septerna is also eligible to receive tiered royalties on global net sales of marketed products. Novo Nordisk will cover all R&D expenses for partnered programs under the collaboration.

Septerna reported a net loss for $(21.5m) in Q1 2025, versus a net loss of $(14.2m) in the prior year period, and reported a cash position of $398m, down from $421m in Q1 2024.

Analysts' ratings for Septerna (NASDAQ:SEPN) over the last quarter vary from bullish to bearish, as provided by 4 analysts. The table below provides a snapshot of their recent ratings, showcasing ...

Septerna, Inc., a clinical-stage biotech firm focused on G protein-coupled receptor (GPCR) drug discovery, has appointed Gil Labrucherie as its new Chief Financial Officer. Labrucherie brings over ...

Septerna (SEPN) struck a deal with Novo Nordisk (NVO) for $2.2 billion for obesity medications. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

SOUTH SAN FRANCISCO, Calif., February 06, 2024--Septerna Appoints Industry Veterans Bernard Coulie, M.D., Ph.D., and Shalini Sharp to its Board of Directors HOME MAIL ...

(Reuters) -Septerna's shares rose about 31% in their market debut on Friday, giving the Goldman Sachs-backed biotech firm a valuation of $970 million. The company's shares opened at $23.5 in their ...

SOUTH SAN FRANCISCO, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug ...

Tuesday, 02 January 2024 12:17 GMT 02 January 2024 12:17 GMT. عربي ...